These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22263235)

  • 21. An OMERACT Initiative Toward Consensus to Identify and Characterize Candidate Contextual Factors: Report from the Contextual Factors Working Group.
    Finger ME; Boonen A; Woodworth TG; Escorpizo R; Christensen R; Nielsen SM; Leong AL; Scholte Voshaar M; Flurey CA; Milman N; Verstappen SM; Alten R; Guillemin F; Kloppenburg M; Beaton DE; Tugwell PS; March LM; Furst DE; Pohl C
    J Rheumatol; 2017 Nov; 44(11):1734-1739. PubMed ID: 28461648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
    Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS
    J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment outcome parameters].
    Burmester GR; Smolen J
    Z Rheumatol; 2009 Feb; 68(1):9. PubMed ID: 19156433
    [No Abstract]   [Full Text] [Related]  

  • 24. The OMERACT First-time Participant Program: Fresh Eye from the New Guys.
    Sloan VS; Grosskleg S; Pohl C; Wells GA; Singh JA
    J Rheumatol; 2017 Oct; 44(10):1560-1563. PubMed ID: 28507185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Standardized outcome parameters].
    Zink A; Albrecht K
    Z Rheumatol; 2016 Aug; 75(6):620-3. PubMed ID: 27379737
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinimetric concepts in outcome assessment: the OMERACT filter.
    Bellamy N
    J Rheumatol; 1999 Apr; 26(4):948-50. PubMed ID: 10229425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updating the OMERACT filter: core areas as a basis for defining core outcome sets.
    Kirwan JR; Boers M; Hewlett S; Beaton D; Bingham CO; Choy E; Conaghan PG; D'Agostino MA; Dougados M; Furst DE; Guillemin F; Gossec L; van der Heijde DM; Kloppenburg M; Kvien TK; Landewé RB; Mackie SL; Matteson EL; Mease PJ; Merkel PA; Ostergaard M; Saketkoo LA; Simon L; Singh JA; Strand V; Tugwell P
    J Rheumatol; 2014 May; 41(5):994-9. PubMed ID: 24634204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of the patient perspective at OMERACT 10--conceptualizing methods for developing patient-reported outcomes.
    Kirwan JR; Tugwell PS
    J Rheumatol; 2011 Aug; 38(8):1699-701. PubMed ID: 21807788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Status versus changes, onset of action, and sustainability--how do we define and present these concepts in clinical trial reports in rheumatology?
    Dougados M
    Bull NYU Hosp Jt Dis; 2011; 69(2):111-5. PubMed ID: 22035389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OMERACT 6 brings new perspectives to rheumatology measurement research.
    Saag KG
    J Rheumatol; 2003 Apr; 30(4):639-41. PubMed ID: 12672177
    [No Abstract]   [Full Text] [Related]  

  • 31. [Role of statisticians in epidemiological research].
    Schlittgen R
    Z Rheumatol; 2015 Mar; 74(2):132-6. PubMed ID: 25805516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.
    Toupin-April K; Barton JL; Fraenkel L; Meara A; Li LC; Brooks P; de Wit M; Stacey D; Légaré F; Shea B; Lyddiatt A; Hofstetter C; Christensen R; Scholte Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Jull JE; Campbell W; Alten R; Karuranga S; Morgan EM; Kelly A; Kaufman J; Hill S; Maxwell LJ; Beaton D; El-Miedany Y; Mittoo S; Bartlett SJ; Singh JA; Tugwell PS
    J Rheumatol; 2019 Oct; 46(10):1409-1414. PubMed ID: 30709963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methodology for clinical trials in rheumatology: logical foundations.
    Cook RJ; Farewell VT; Gladman DD
    J Rheumatol; 1997 Oct; 24(10):1861-5. PubMed ID: 9330922
    [No Abstract]   [Full Text] [Related]  

  • 34. Proceedings from the 5th Annual International Society for Musculoskeletal Imaging in Rheumatology Annual Conference.
    Conaghan PG; Ostergaard M; D'Agostino MA; Gaylis N; Arnold W; Olech E; Wells A; Peterfy C; Seraphine JL; Troum O
    Semin Arthritis Rheum; 2013 Feb; 42(4):433-46. PubMed ID: 23415135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rheumatology day care and the impact of biological therapies-the Belfast experience.
    Cairns AP; Wright SA; Patton JD; Campalani E; Taggart AJ
    Rheumatology (Oxford); 2002 Mar; 41(3):356-7. PubMed ID: 11934983
    [No Abstract]   [Full Text] [Related]  

  • 36. Network in pediatric rheumatology: the example of pediatric rheumatology international trials organisation.
    Ruperto N; Martini A
    Georgian Med News; 2008 Mar; (156):68-74. PubMed ID: 18403813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OMERACT Definitions for Ultrasonographic Pathologies and Elementary Lesions of Rheumatic Disorders 15 Years On.
    Bruyn GA; Iagnocco A; Naredo E; Balint PV; Gutierrez M; Hammer HB; Collado P; Filippou G; Schmidt WA; Jousse-Joulin S; Mandl P; Conaghan PG; Wakefield RJ; Keen HI; Terslev L; D'Agostino MA;
    J Rheumatol; 2019 Oct; 46(10):1388-1393. PubMed ID: 30709946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consensus Building in OMERACT: Recommendations for Use of the Delphi for Core Outcome Set Development.
    Humphrey-Murto S; Crew R; Shea B; Bartlett SJ; March L; Tugwell P; Maxwell LJ; Beaton D; Grosskleg S; de Wit M
    J Rheumatol; 2019 Aug; 46(8):1041-1046. PubMed ID: 30770512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement.
    Ruperto N; Ravelli A; Oliveira S; Alessio M; Mihaylova D; Pasic S; Cortis E; Apaz M; Burgos-Vargas R; Kanakoudi-Tsakalidou F; Norambuena X; Corona F; Gerloni V; Hagelberg S; Aggarwal A; Dolezalova P; Saad CM; Bae SC; Vesely R; Avcin T; Foster H; Duarte C; Herlin T; Horneff G; Lepore L; van Rossum M; Trail L; Pistorio A; Andersson-Gäre B; Giannini EH; Martini A;
    Arthritis Rheum; 2006 Jun; 55(3):355-63. PubMed ID: 16739203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental rheumatology--on the way to a fundamental understanding of rheumatic diseases].
    Radbruch A
    Z Rheumatol; 2005 Sep; 64(6):367-9. PubMed ID: 16184342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.